Wellington Management Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Wellington Management Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-17,521,066	Closed	-$218M	–	2390
2016 Q4	$218M	Buy	17,521,066 +380,574	+2%	+$4.58M	0.05%	303
2016 Q3	$235M	Buy	+17,140,492	New	+$172M	0.06%	288
2015 Q4	–	Sell	-299,832	Closed	-$1.75M	–	2316
2015 Q3	$1.75M	Buy	299,832 +168,064	+128%	+$1.29M	﹤0.01%	1680
2015 Q2	$1.09M	Buy	+131,768	New	+$1.17M	﹤0.01%	1822
2015 Q1	–	Sell	-31,100	Closed	-$214K	–	2287
2014 Q4	$214K	Sell	31,100 -13,000	-29%	-$81.3K	﹤0.01%	2126
2014 Q3	$238K	Buy	+44,100	New	+$258K	﹤0.01%	2111

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

Wellington Management Group's ARIA Position: Q1 2017 in Review

Wellington Management Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 17,521,066 shares — an estimated $218M sold.

Wellington Management Group first reported a position in ARIA in Q3 2014 and held it in 6 quarters. The position peaked at $235M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Wellington Management Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Wellington Management Group sold 17,521,066 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $218M.
Wellington Management Group first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 6 quarters.
Wellington Management Group's Ariad Pharmaceuticals Inc position peaked at $235M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Wellington Management Group's 13F filing for Q1 2017, filed 11 May 2017.